1 / 6
Laboratory Research Material
KPV
10 mg per vial · Lyophilized powder
Laboratory Research Material
KPV 10 mg per vial
$89.99
- Compound
- KPV
- Amount per vial
- 10 mg
- Form
- Lyophilized powder
- Packaging
- 1 × 3 mL vial, boxed
- Shipping
- FedEx 2DayShips from the U.S. Estimated arrival2 business days after dispatchWeekday dispatch · 4 p.m. ET cutoff
Delivery details
Estimated for in-stock orders using FedEx 2Day. Weekends and FedEx closures are excluded. Holiday pickups, destination and carrier delays can affect arrival. Alaska and Hawaii may take longer.
Free U.S. shipping on orders $199+
Important
Research Use Notice
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.
Product Documentation
Details, specifications, and documents
Description
KPV 10 mg: research material
Buy KPV 10 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.
KPV is the tripeptide lysine-proline-valine, corresponding to the C-terminal three-residue sequence of alpha-melanocyte-stimulating hormone (alpha-MSH). It is studied in peptide transport and inflammatory-signaling models.
Choose the material and presentation
This 10 mg product is single-compound KPV. It differs from full-length alpha-MSH and from the KLOW and Tri-Heal blends, whose total mass includes other ingredients. Compare the individual compound amounts when a study calls for KPV alone.
The labeled mass is not a concentration or an experimental dose. Match the peptide identity and any specified terminal chemistry or salt form to your method. The three-letter name identifies the residue sequence; the applicable material records provide the supplied-product details.
KPV uptake and inflammatory signaling
Intestinal epithelial and immune-cell models
Dalmasso and colleagues studied KPV in intestinal epithelial cell lines and Jurkat T cells. They used uptake experiments alongside NF-kappaB reporter, protein and cytokine assays. Their results linked the PepT1 di/tripeptide transporter to cellular uptake and lower activation of selected NF-kappaB and MAP kinase pathways.
The study also examined two chemically induced mouse-colitis models. These experiments help distinguish transport, pathway measurements and tissue-level outcomes. They do not establish a human treatment effect or a dosing schedule for this research material.
Mechanism depends on the cell system
In a separate study of immortalized human bronchial epithelial cells, Land compared KPV with gamma-MSH. KPV reduced nuclear entry of the NF-kappaB component p65RelA; gamma-MSH’s response instead required the melanocortin-3 receptor, MC3R, in that model. The work measured reporter activity and inflammatory signaling, including IL-8 and eotaxin secretion.
The comparison shows why a relationship to melanocortin peptides does not imply identical receptor dependence. Record the cell type, stimulus, uptake conditions and measured endpoint when assessing a KPV experiment.
Product records and batch reports
Review available lot reports and product files in the product documentation section. Check the product and lot identifiers, then read identity, chromatographic purity and measured content as separate results.
Use the applicable material instructions for handling and storage. A general paper about KPV, or another supplier’s preparation instructions, does not verify this batch’s chemical form, stability or suitability for a particular assay.
Additional information
| Purity | ≥99% |
|---|---|
| Sequence | Lys-Pro-Val |
| Molecular Formula | C16H30N4O4 (reference molecule; excludes counterions and fillers) |
| Molecular Weight | 342.43 g/mol (reference molecule; excludes counterions and fillers) |
| Applications | In-vitro assay research, compound characterization, analytical method development |
| Synthesis | Solid-phase synthesis |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
COA & Documents
Independent lot testing
KPV 10mg Certificate of Analysis
This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.
- Lot number
- 57460
- Report number
- IF-824-QSA-TR006-BTL2649-13
- Date tested
- March 18, 2026
- Reported purity
- 99.5%
- Labeled content
- 10 mg
Product documents
Product information and laboratory resources. For lot-specific results, use the COA above.
Product & packaging information
Labeled amount, physical form and packaging for KPV 10mg.
Revision 0.4 · 2026-10-05Download PDFLaboratory handling guide
General guidance for applicable lyophilized research materials. Not a product-specific SDS.
Revision 1.0 · 2026-09-22Download PDFGeneral guides & resources
Reading a COA & Verifying Your Lot
PDF · Revision 1.0Receiving, Storage & Traceability Record
PDF · Revision 1.0Research Use & Documentation Scope
PDF · Revision 1.0Need Assistance?
Questions about product documentation?
Contact our support team for help with product records, lot information, orders or certificate verification.
